Goals of Therapy - Squeeze the Pipes
- Primary Goal: Maintain Mean Arterial Pressure (MAP) ≥ 65 mmHg to ensure adequate organ perfusion.
- MAP is estimated as $1/3(SBP) + 2/3(DBP)$.
⭐ Add Dobutamine for persistent hypoperfusion (e.g., elevated lactate) and evidence of myocardial dysfunction (e.g., low cardiac index on echo) despite achieving the MAP goal.
Norepinephrine - The Alpha Dog
- First-line vasopressor for septic shock (Surviving Sepsis Campaign).
- Mechanism: Potent α1-agonist >> β1-agonist activity.
- α1 stimulation → intense peripheral vasoconstriction → ↑ SVR & ↑ MAP.
- β1 stimulation → modest ↑ inotropy & chronotropy → ↑ Cardiac Output.
- Hemodynamic Profile:
- Primarily ↑ MAP through ↑ SVR.
- Cardiac output may increase, stay stable, or decrease (due to reflex bradycardia).
⭐ Exam Favorite: Norepinephrine is superior to dopamine for septic shock as it's associated with a lower risk of arrhythmias and improved mortality.
Adjunctive Agents - The Backup Squeezers
- Vasopressin: For refractory shock to ↓ norepinephrine needs. Acts on V1 receptors causing pure vasoconstriction. Typical dose is 0.03 units/minute.
- Epinephrine: Add-on therapy if MAP targets are unmet. Potent β1 and α1 effects, but risk of tachyarrhythmias and ↑ lactate.
- Corticosteroids: Consider for refractory shock despite adequate fluids and pressors.
- Hydrocortisone IV, often 200 mg/day.
⭐ For patients on norepinephrine or epinephrine, adding vasopressin is associated with a lower rate of atrial fibrillation. It acts as a catecholamine-sparing agent.
Inotropic Support - Whip the Heart
Used for persistent hypoperfusion and cardiac dysfunction despite adequate fluid and vasopressor therapy (MAP ≥65 mmHg).
- Goal: Increase cardiac output (CO) and improve end-organ perfusion.
- Primary Agent: Dobutamine
- Mechanism: Primarily a β1-agonist → ↑ contractility & heart rate.
- Dosing: 2-20 mcg/kg/min.
- Alternative: Epinephrine
- Provides both potent inotropic (β1) and vasopressor (α1) support.
⭐ Dobutamine's β2-agonist activity can cause peripheral vasodilation, potentially worsening hypotension. Ensure patient is on a vasopressor first.
Monitoring & Titration - Watchful Waiting
- Goal: Titrate to the lowest effective dose to maintain target MAP (>65 mmHg) and ensure adequate end-organ perfusion.
- Frequent Reassessment:
- Arterial Line: For continuous, real-time MAP monitoring.
- Lactate Clearance: Check q4-6h; indicates resolving shock.
- Urine Output: Target >0.5 mL/kg/hr.
- CVP & ScvO2: Targets 8-12 mmHg & >70% respectively.
- Weaning: Gradually ↓ dose when stable and lactate normalizes. Avoid abrupt discontinuation.
⭐ Persistent ↑ lactate despite an adequate MAP is a poor prognostic sign, suggesting ongoing tissue hypoperfusion or mitochondrial dysfunction.

High‑Yield Points - ⚡ Biggest Takeaways
- Norepinephrine is the first-line vasopressor for septic shock, targeting a MAP ≥65 mmHg.
- Vasopressin is a common second-line agent added to norepinephrine; it is not titrated.
- Add dobutamine for signs of myocardial dysfunction (e.g., low cardiac output) despite adequate fluid and vasopressor therapy.
- Epinephrine can be an alternative or add-on to norepinephrine.
- An arterial line is essential for accurate, continuous blood pressure monitoring.
- Watch for peripheral ischemia as a major side effect.
Continue reading on Oncourse
Sign up for free to access the full lesson, plus unlimited questions, flashcards, AI-powered notes, and more.
CONTINUE READING — FREEor get the app